Last reviewed · How we verify
Prilocaine Hydrochloride 2% Injection
Prilocaine Hydrochloride 2% Injection is a Small molecule drug developed by Assiut University. It is currently FDA-approved. Also known as: Takipril.
At a glance
| Generic name | Prilocaine Hydrochloride 2% Injection |
|---|---|
| Also known as | Takipril |
| Sponsor | Assiut University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of Combined Nanofat Injection With Either Platelet Rich Fibrin or Microneedling Versus Nanofat Injection Alone in the Treatment of Facial Atrophic Post Acne Scars (NA)
- Does Botulinum Toxin Type-A Injection an Effective Way of Relieving Pain in Myofascial Pain Syndrome Patients or Not (NA)
- Effect of Subarachnoid Block and Femoropopliteal Block to Limb Perfusion in PAD Patients (NA)
- Pain Control Following Total Hip Arthroplasty (PHASE1)
- Comparison of the Short-term Clinical Effects of Anterior Extra-articular and Posterior Intra-articular Administration of Ultrasound-guided Steroid Injection in the Treatment of Adhesive Capsulitis. (NA)
- Double-dorsal Versus Single-volar Digital Block (NA)
- Comparing Autologous Blood, Corticosteroid, and Their Combined Injection for Treating Lateral Epicondylitis (NA)
- The Effects of Two Different Treatment Protocols on Shoulder Function, Quality of Life, and Ultrasound Parameters in Patients With Frozen Shoulder (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Prilocaine Hydrochloride 2% Injection CI brief — competitive landscape report
- Prilocaine Hydrochloride 2% Injection updates RSS · CI watch RSS
- Assiut University portfolio CI
Frequently asked questions about Prilocaine Hydrochloride 2% Injection
What is Prilocaine Hydrochloride 2% Injection?
Prilocaine Hydrochloride 2% Injection is a Small molecule drug developed by Assiut University.
Who makes Prilocaine Hydrochloride 2% Injection?
Prilocaine Hydrochloride 2% Injection is developed and marketed by Assiut University (see full Assiut University pipeline at /company/assiut-university).
Is Prilocaine Hydrochloride 2% Injection also known as anything else?
Prilocaine Hydrochloride 2% Injection is also known as Takipril.
What development phase is Prilocaine Hydrochloride 2% Injection in?
Prilocaine Hydrochloride 2% Injection is FDA-approved (marketed).
Related
- Manufacturer: Assiut University — full pipeline
- Also known as: Takipril